More importantly, it was very recently reported that RPS6KA1 may be a strong indicator of overall survival in AML patients, while aberrations in the miR-138-5p/RPS6KA1 axis are associated with poor prognosis among patients [44]. This evidence concerns the gene RPS6KA1 and acute myeloid leukemia.